NIAID workshop on flavivirus immunity

Viral Immunology

Volumn 23, Issue 3, 2010, Pages 235-240

  Augustine, Alison D ^a   Cassetti, M Cristina ^a   Ennis, Francis A ^b   Harris, Eva ^c   Hildebrand, William H ^d   Repik, Patricia M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; DENGUE VACCINE; EPITOPE; JAPANESE ENCEPHALITIS VACCINE; T LYMPHOCYTE ANTIGEN; TICK BORNE ENCEPHALITIS VACCINE; WEST NILE VACCINE; YELLOW FEVER VACCINE; VIRUS VACCINE;

ADAPTIVE IMMUNITY; AEDES AEGYPTI; B LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL TRIAL; COHORT ANALYSIS; DENGUE; DENGUE VIRUS; DRUG EFFICACY; DRUG SAFETY; FLAVIVIRUS; FLAVIVIRUS INFECTION; HOST PATHOGEN INTERACTION; HUMAN; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; MORTALITY; MURRAY VALLEY ENCEPHALITIS; MURRAY VALLEY ENCEPHALITIS VIRUS; NONHUMAN; NOTE; PATHOGENESIS; PROSPECTIVE STUDY; ST LOUIS FLAVIVIRUS; ST. LOUIS ENCEPHALITIS; SYMPTOM; T LYMPHOCYTE; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VIRUS IMMUNITY; VIRUS STRAIN; VIRUS TRANSMISSION; WEST NILE FEVER; WEST NILE FLAVIVIRUS; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS; CONFERENCE PAPER; IMMUNOLOGY; MEDICAL RESEARCH; NATIONAL HEALTH ORGANIZATION; UNITED STATES;

FLAVIVIRIDAE; FLAVIVIRUS;

BIOMEDICAL RESEARCH; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (U.S.); UNITED STATES; VIRAL VACCINES;

EID: 77954156236     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2009.0114     Document Type: Note

References (32)

1. Altman JD, Moss PA, Goulder PJ, et al.: Phenotypic analysis of antigen-specific T lymphocytes. Science 1998;274:94-96.
2. Barrett AD, and Teuwen DE: Yellow fever vaccine-how does it work and why do rare cases of serious adverse events take place? Curr Opin Immunol 2009;21:308-313.
3. Belsher JL, Gay P, Brinton M, et al.: Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease. Vaccine 2007;25:8480-8485.
4. Blythe MJ, Zhang Q, Vaughan K, et al.: An analysis of the epitope knowledge related to Mycobacteria. Immunome Res 2007;3:105.
5. Brien JD, Uhrlaub JL, Hirsch A, Wiley CA, and Nikolich- Zugich J: Key role of T cell defects in age-related vulnerability to West Nile virus. J Exp Med 2009;206:2735-2745.
6. Brien JD, Uhrlaub JL, and Nikolich-Zugich J: West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J Immunol 2008;181:8568-8575.
7. Bui HH, Peters B, Assarsson E, Mbawuike I, and Sette A: Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci USA 2007;104:246-251.
8. Capeding RZ, Brion JD, Caponpon MM, Gibbons RV, Jarman RG, Yoon IK, and Libraty DH: The incidence, characteristics, and presentation of dengue virus infections during infancy. Am J Trop Med Hyg 2010;82:330-336.
9. Diamond MS, Mehlhop E, Oliphant T, and Samuel MA; The host immunologic response to West Nile encephalitis virus. Front Biosci 2009;14:3024-3034.
10. Doblas A, Domingo C, Bae HG, et al.: Yellow fever vaccineassociated viscerotropic disease and death in Spain. J Clin Virol 2006;36:156-158.
11. Endy TP, Yoon IK, and Mammen MP: Prospective cohort studies of dengue viral transmission and severity of disease. Curr Top Microbiol Immunol 2010;338:1-13.
12. Engel AR, Vasconcelos PF, McArthur MA, and Barrett AD: Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil. Vaccine 2006;24:2803-2809.
13. Gould EA, and Solomon T: Pathogenic flaviviruses. Lancet 2008;371:500-509.
14. Gritsun TS, Lashkevich VA, and Gould EA: Tick-borne encephalitis. Antiviral Res 2003;57:129-146.
15. Gubler D, Kuno G, and Markoff L: Flaviviruses. In: Fields Virology, 5th ed., Vol.1. (Knipe DM, and Howley PM, eds.). Lippincott Williams & Wilkins, Philadelphia, 2007, pp. 1153-1253.
16. Hayes EB, Komar N, Nasci RS, Montgomery SP, O'Leary DR, and Campbell GL: Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis 2005; 11:1167-1173.
17. King NJ, Getts DR, Getts MT, Rana S, Shrestha B, and Kesson AM: Immunopathology of flavivirus infections. Immunol Cell Biol 2007;85:33-42.
18. Lanteri MC, O'Brien KM, Purtha WE, et al.: Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest 2009;119:3266-3277.
19. Lindsey NP, Schroeder BA, Miller ER, et al.: Adverse event reports following yellow fever vaccination. Vaccine 2008;26: 6077-6082.
20. Mansfield KL, Johnson N, Phipps LP, Stephenson JR, Fooks AR, and Solomon T: Tick-borne encephalitis virus-a review of an emerging zoonosis. J Gen Virol 2009;90:1781-1794.
21. Matthew A, and Rothman AL: Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol Rev 2008;225:300-313.
22. McMahon AW, Eidex RB, Marfin AA, et al.: Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases. Vaccine 2007;25:1727-1734.
23. Peters B, Sidney J, Bourne P, et al.: The immune epitope database and analysis resource: from vision to blueprint. PLoS Biol 2005;3:e91.
24. Pierson TC, and Diamond MS: Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection. Expert Rev Mol Med 2008;10:e12.
25. Rothman AL: T lymphocyte responses to heterologous secondary dengue virus infections. Ann NY Acad Sci 2009; 1171(Suppl 1):E36-E41.
26. Sitati EM, and Diamond MS: CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. J Virol 2006;80:12060-12069.
27. Stephens HA: HLA and other gene associations with dengue disease severity. Curr Top Microbiol Immunol 2010;338: 99-114.
28. Vasilakis N, and Weaver SC: The history and evolution of human dengue emergence. Adv Virus Res 2008;72:1-76.
29. Vaughan K, Blythe M, Greenbaum J, et al.: Meta-analysis of immune epitope data for all plasmodia: overview and applications for malarial immunobiology and vaccine-related issues. Parasite Immunol 2009;32:78-97.
30. Vaughn K, Greenbaum J, Blythe M, Peters B, and Sette A: Meta-analysis of All Immunie Epitope Data in the Flavivirus Genus: Inventory of Current Immune Epitope Data Status in the Context of Virus Immunity and Immunopathology. Viral Immunol 2010;23:259-284..
31. World Health Organization: Fact sheet no. 117. Revised May 2008 http://www.who.int/mediacentre/factsheets/fs117/en/ (accessed 21.11.2008).
32. Zarebski LM, et al.: Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum. Expert Rev Vaccines 2008;7:55-74.